A. Sniderman

K. Cianflone, A. Sniderman, 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

Levels of acylation stimulating protein in obese women before and after moderate weight loss.

R. Eckel, K. Cianflone, Sniderman Ad, 1991, International journal of obesity.

Enhanced triglyceride clearance with intraperitoneal human acylation stimulating protein in C57BL/6 mice.

K. Cianflone, A. Sniderman, I. Murray, 1999, The American journal of physiology.

Impaired response of fibroblasts from patients with hyperapobetalipoproteinemia to acylation-stimulating protein.

K. Cianflone, M. Maslowska, A. Sniderman, 1990, The Journal of clinical investigation.

Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge.

K. Cianflone, Z. Yasruel, A. Sniderman, 1990, Journal of lipid research.

Acylation stimulating protein: myth, magic, or major metabolic player.

A. Sniderman, 1999, Obesity research.

Role of the neutral lipid accessible pool in the regulation of secretion of apoB-100 lipoprotein particles by HepG2 cells.

K. Cianflone, R. K. Avramoglu, A. Sniderman, 1995, Journal of lipid research.

The acylation stimulating protein-adipsin system.

K. Cianflone, A. Sniderman, M. Maslowska, 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

Acylation stimulating protein (ASP), an adipocyte autocrine: new directions.

K. Cianflone, M. Maslowska, A. Sniderman, 1999, Seminars in cell & developmental biology.

Pathogenesis of carbohydrate-induced hypertriglyceridemia using HepG2 cells as a model system.

K. Cianflone, J. Monge, A. Sniderman, 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

Role of cholesterol ester mass in regulation of secretion of ApoB100 lipoprotein particles by hamster hepatocytes and effects of statins on that relationship.

K. Cianflone, Z. Zhang, A. Sniderman, 1999, Arteriosclerosis, thrombosis, and vascular biology.

Adipsin/acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis.

K. Cianflone, A. Sniderman, M. Maslowska, 1994, Biochemistry.

The pathogenetic role of impaired fatty acid trapping by adipocytes in generating the pleiotropic features of hyperapoB

K. Cianflone, K. Frayn, A. Sniderman, 1997, Diabetologia.

The acylation-stimulating protein pathway and regulation of postprandial metabolism

K. Cianflone, B. Fielding, K. Frayn, 1997, Proceedings of the Nutrition Society.

Metabolic response of Acylation Stimulating Protein to an oral fat load.

K. Cianflone, A. Sniderman, A. Sniderman, 1989, Journal of lipid research.

Increase in intracellular triglyceride synthesis induced by gemfibrozil.

K. Cianflone, A. Sniderman, A. Baldo, 1994, Metabolism: clinical and experimental.

Differential binding of triglyceride-rich lipoproteins to lipoprotein lipase.

K. Cianflone, A. Sniderman, A. Sniderman, 1999, Journal of lipid research.

Tendon xanthomas associated with cholestanolosis and hyperapobetalipoproteinemia.

J. Davignon, C. Roy, S. Lussier‐Cacan, 1986, Clinical and investigative medicine. Medecine clinique et experimentale.

Errors that result from using the TC/HDL C ratio rather than the apoB/apoA‐I ratio to identify the lipoprotein‐related risk of vascular disease

I. Holme, A. Aastveit, G. Walldius, 2006, Journal of internal medicine.

Divergent responses of the liver to increased delivery of glucose or fatty acids: implications for the pathogenesis of type IV hyperlipoproteinemia.

K. Cianflone, A. Sniderman, Z. Zhang, 1998, Atherosclerosis.

Hypertrophy and hyperplasia of abdominal adipose tissues in women

A. Tchernof, A. Sniderman, M. Fortier, 2008, International Journal of Obesity.

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel

R. Krauss, S. Humphries, C. Furberg, 2006, Journal of internal medicine.

Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period.

K. Cianflone, B. Fielding, K. Frayn, 1998, Journal of lipid research.

K. Cianflone, P. Havel, A. Sniderman, 2022 .

Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment

A. Keech, C. Furberg, A. Wägner, 2003, The Lancet.

Efficacy and safety of a new hydroxymethylglutaryl-coenzyme A reductase inhibitor, atorvastatin, in patients with combined hyperlipidemia: comparison with fenofibrate.

A. Sorisky, T. Ooi, L. Leiter, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Mice lacking acylation stimulating protein (ASP) have delayed postprandial triglyceride clearance.

K. Cianflone, A. Sniderman, A. Sniderman, 1999, Journal of lipid research.

Plasma acylation-stimulating protein in coronary artery disease.

K. Cianflone, J. Genest, X. J. Zhang, 1997, Arteriosclerosis, thrombosis, and vascular biology.

ASP stimulates glucose transport in cultured human adipocytes

K. Cianflone, R. Germinario, A. Sniderman, 1997, International Journal of Obesity.

Measurement of apoproteins: time to improve the diagnosis and treatment of the atherogenic dyslipoproteinemias.

K. Cianflone, A. Sniderman, 1996, Clinical chemistry.

The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis.

K. Cianflone, A. Sniderman, M. Maslowska, 1993, The Journal of clinical investigation.

Postprandial hypertriglyceridemia(s): time to enlarge our pathophysiologic perspective

A. Sniderman, A. Sniderman, 2000, European journal of clinical investigation.

Modulation of chylomicron remnant metabolism by an hepatic hydroxymethylglutaryl coenzyme A reductase inhibitor.

K. Cianflone, M. Bilodeau, J. Davignon, 1990, Metabolism: Clinical and Experimental.

Purification and characterization of acylation stimulating protein.

K. Cianflone, A. Sniderman, A. Sniderman, 1989, The Journal of biological chemistry.

Stimulation of fatty acid uptake and triglyceride synthesis in human cultured skin fibroblasts and adipocytes by a serum protein.

K. Cianflone, P. Kwiterovich, A. Sniderman, 1987, Biochemical and biophysical research communications.

Lipoproteins and cardiovascular risk

G. Walldius, I. Jungner, C. Furberg, 2003, The Lancet.

Enhanced dietary fat clearance in postobese women.

K. Cianflone, M. Faraj, A. Sniderman, 2001, Journal of lipid research.

The adipsin-acylation-stimulating protein pathway and microenvironmental metabolic regulation.

K. Cianflone, A. Sniderman, 1997, World review of nutrition and dietetics.

The effect of ASP on the adipocyte of the morbidly obese.

K. Cianflone, R. A. Forse, A. Sniderman, 1989, The Journal of surgical research.

Regulation by retinoic acid of acylation-stimulating protein and complement C3 in human adipocytes.

K. Cianflone, A. Sniderman, T. Scantlebury, 2001, The Biochemical journal.

Acylation-stimulating protein (ASP) regulates glucose transport in the rat L6 muscle cell line.

K. Cianflone, R. Germinario, S. Colby-Germinario, 1997, Biochimica et biophysica acta.

Coordinate regulation of triacylglycerol synthesis and glucose transport by acylation-stimulating protein.

K. Cianflone, R. Germinario, A. Sniderman, 1993, Metabolism: clinical and experimental.